Clinical Trial Results:
Multi-center, randomized, evaluator-blind,
active-controlled, parallel-group design to determine safety, tolerability, and efficacy of multiple daily administration of LFF571 for 10 days in patients with moderate Clostridium difficile infections (Cohort 2)
Summary
|
|
EudraCT number |
2011-000947-26 |
Trial protocol |
ES PT |
Global completion date |
17 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Oct 2016
|
First version publication date |
07 Oct 2016
|
Other versions |
|
Summary report(s) |
CLFF571X2201.CTR.01Sept2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.